Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 5CNS 2

Conditions

Neoplasms 5

Interventions

Surveys and Questionnaires 65pembrolizumab 56Gemcitabine 54Paclitaxel 51Blood Specimen Collection 45Carboplatin 44Bevacizumab 41Docetaxel 38Cisplatin 33Nivolumab 32Fluorouracil 31Capecitabine 28Radiotherapy 25Pemetrexed 25Irinotecan 25Standard of Care 24Interviews as Topic 24Magnetic Resonance Spectroscopy 23Leucovorin 22Erlotinib Hydrochloride 22atezolizumab 21Cetuximab 21Afatinib 21Oxaliplatin 19trametinib 18Exercise 18Ipilimumab 17Sorafenib 16Cyclophosphamide 16olaparib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Neoplasms × Mental Status and Dementia Tests × Tumor-Agnostic × Clear all
NCT00772200 2025-09-18

Neuropsychological and Behavioral Testing in Younger Patients With Cancer

Children's Oncology Group

Active not recruiting
1,200 enrolled
Tumor-Agnostic

Neoplasms

NCT06160700 2024-06-10

Serial Testing To Assess Cognitive Function In Cancer

Indiana University

Terminated
54 enrolled
Tumor-Agnostic

Neoplasms

NCT01506440 2018-07-03

Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy

Wake Forest University Health Sciences

Completed
29 enrolled
Tumor-Agnostic

Neoplasms

NCT02558907 2017-04-04

MoCA

Centre Francois Baclesse

Completed
66 enrolled
Tumor-Agnostic

Neoplasms

NCT03052868 2017-02-14

Analysis of Neurocognitive Elements of Attention After Chemotherapy

University of Texas Southwestern Medical Center

Phase NA Completed
75 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡